81 related articles for article (PubMed ID: 24295561)
1. Elevated serum levels of circulating immunoinflammation-related protein complexes are associated with cancer.
Wang Y; Song G; Wang Y; Qiu L; Qin X; Liu H; Li F; Wang X; Li F; Guo S; Zhang Y; Li Z
J Proteome Res; 2014 Feb; 13(2):710-9. PubMed ID: 24295561
[TBL] [Abstract][Full Text] [Related]
2. Personalized biomarkers to monitor disease progression in advanced non-small-cell lung cancer patients treated with icotinib.
Song G; Liu Y; Wang Y; Ren G; Guo S; Ren J; Zhang L; Li Z
Clin Chim Acta; 2015 Feb; 440():44-8. PubMed ID: 25447696
[TBL] [Abstract][Full Text] [Related]
3. Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer.
Sun YH; Li J; Shu HJ; Li ZL; Qian JM
Clin Transl Oncol; 2019 Dec; 21(12):1680-1686. PubMed ID: 30955196
[TBL] [Abstract][Full Text] [Related]
4. Increased Levels of Serum Protein Complexes Are Associated with Type 2 Diabetes.
Liu Y; Wu Y; Wang Y; Zhang M; Li Z
Int J Med Sci; 2018; 15(3):210-216. PubMed ID: 29483811
[No Abstract] [Full Text] [Related]
5. Elevated serum immunoinflammation-related protein complexes are associated with psychosis.
Liu Y; Zhang D; Cheng Y; Li Z
Psychiatry Res; 2015 Nov; 230(1):96-101. PubMed ID: 26337482
[TBL] [Abstract][Full Text] [Related]
6. Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer.
Ohki S; Shibata M; Gonda K; Machida T; Shimura T; Nakamura I; Ohtake T; Koyama Y; Suzuki S; Ohto H; Takenoshita S
Oncol Rep; 2012 Aug; 28(2):453-8. PubMed ID: 22614133
[TBL] [Abstract][Full Text] [Related]
7. Serum immunoinflammatory-related protein complexes as personalized biomarkers for monitoring disease progression and response to treatment in lung cancer patients.
Zhang H; Li D; Lai Z; Zhou J; Zhang J; Li Z
Clin Chim Acta; 2022 Aug; 533():53-62. PubMed ID: 35714939
[TBL] [Abstract][Full Text] [Related]
8. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer.
Allin KH; Nordestgaard BG
Crit Rev Clin Lab Sci; 2011; 48(4):155-70. PubMed ID: 22035340
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Exploration of changes in serum immunoinflammation-related protein complexes of patients with metastatic breast cancer.
Chen C; Xu Y; Lai Z; Li Z; Sun Q
Front Oncol; 2023; 13():1207991. PubMed ID: 37546392
[TBL] [Abstract][Full Text] [Related]
10. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.
Cao M; Yie SM; Liu J; Ye SR; Xia D; Gao E
Tissue Antigens; 2011 Aug; 78(2):120-8. PubMed ID: 21726203
[TBL] [Abstract][Full Text] [Related]
11. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.
Gao WM; Kuick R; Orchekowski RP; Misek DE; Qiu J; Greenberg AK; Rom WN; Brenner DE; Omenn GS; Haab BB; Hanash SM
BMC Cancer; 2005 Aug; 5():110. PubMed ID: 16117833
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of gastric cancer by serum proteomic fingerprinting.
Poon TC; Sung JJ; Chow SM; Ng EK; Yu AC; Chu ES; Hui AM; Leung WK
Gastroenterology; 2006 May; 130(6):1858-64. PubMed ID: 16697748
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer.
Jackson D; Craven RA; Hutson RC; Graze I; Lueth P; Tonge RP; Hartley JL; Nickson JA; Rayner SJ; Johnston C; Dieplinger B; Hubalek M; Wilkinson N; Perren TJ; Kehoe S; Hall GD; Daxenbichler G; Dieplinger H; Selby PJ; Banks RE
Clin Cancer Res; 2007 Dec; 13(24):7370-9. PubMed ID: 18094419
[TBL] [Abstract][Full Text] [Related]
14. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer.
Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S397-405. PubMed ID: 22956063
[TBL] [Abstract][Full Text] [Related]
15. Relevance of histone marks H3K9me3 and H4K20me3 in cancer.
Leszinski G; Gezer U; Siegele B; Stoetzer O; Holdenrieder S
Anticancer Res; 2012 May; 32(5):2199-205. PubMed ID: 22593510
[TBL] [Abstract][Full Text] [Related]
16. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
17. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
[TBL] [Abstract][Full Text] [Related]
18. Quantification of plasma DNA as a screening tool for lung cancer.
Xie GS; Hou AR; Li LY; Gao YN; Cheng SJ
Chin Med J (Engl); 2004 Oct; 117(10):1485-8. PubMed ID: 15498370
[TBL] [Abstract][Full Text] [Related]
19. Copper, zinc and superoxide dismutase in precancerous, benign diseases and gastric, colorectal and breast cancer.
Magálová T; Bella V; Brtková A; Beno I; Kudlácková M; Volkovová K
Neoplasma; 1999; 46(2):100-4. PubMed ID: 10466433
[TBL] [Abstract][Full Text] [Related]
20. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
